Status | Study |
RECRUITING |
Study Name: Atezolizumab for Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2022-08-12 Interventions: Atezolizumab 1200 mg administered via intravenous infusion every 3 weeks |
RECRUITING |
Study Name: To Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF Condition: Idiopathic Pulmonary Fibrosis Date: 2022-07-27 Interventions: BBT-877 24 weeks + Follow-up 4 weeks |
RECRUITING |
Study Name: A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2022-05-20 Interventions: Caveolin-1-Scaffolding-Protein-Derived Peptide |
RECRUITING |
Study Name: A Study to Evaluate LTI-03 in Newly Diagnosed Idiopathic Pulmonary Fibrosis (IPF) Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2022-05-20 Interventions: Caveolin-1-Scaffolding-Protein-Derived Peptide |
RECRUITING |
Study Name: Study of Oral Epigallocatechin-3-gallate (EGCG) in IPF Patients Condition: Idiopathic Pulmonary Fibrosis Date: 2021-12-02 Interventions: Dietary Supplement: EGCG Capsules with Teavigo EGCG (at least 94% purity).300 mg EGCG (2 capsules) taken orally daily for 12 weeks.Dru |
RECRUITING |
Study Name: Inhaled Nitric Oxide (iNO) in Idiopathic Pulmonary Fibrosis (IPF). Condition: Idiopathic Pulmonary Fibrosis Date: 2021-09-02 Interventions: Nitric oxide gas for inhalation |
COMPLETED |
Study Name: Neuromuscular Electrical Stimulation in Patients With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2019-03-13 Interventions: A 20-30 minutes low-medium intensity aerobic exercise training with cycling ergometer. |
Not yet recruiting |
Study Name: Yoga Effect on Quality of Life Study Among Patients With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2016-07-26 Interventions: Other: Yoga Yoga and breathing exercises designed for patients with IPF. Sessions will be two times per |
Recruiting |
Study Name: Clinical Study of ART-123 for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2016-04-01 Interventions: Drug: ART-123 380 U/kg/day by |
Completed |
Study Name: A Safety and Tolerability Study of Oral Vismodegib in Combination With Pirfenidone in Participants With Idiopathic Pulmonary Fibrosis Condition: Idiopathic Pulmonary Fibrosis Date: 2016-01-05 Interventions: Drug: Pirfenidone Participants |